Evicenter
P&T meetings

Ulixacaltamide

Essential tremor

Regulatory submission
NDA submitted by February 2026
Launch
Not announced
Last updated
78 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Essential tremor

Economic impact of Essential tremor on families

3 evidence topics · 3 sources